Alto Neuroscience

Overview

Alto Neuroscience is a US provider of drugs for mental health treatment.

Funding · 2

Amounts as reported; USD estimates shown only when they match

Listed 2 funding records. Latest funding: $45M (Series C), Nov 23, 2023.

Annual trendUnit: USD

Date	Amount	Investors	Sources
Nov 23, 2023	$45M · Series C	Alexandria Venture Investments, Alpha Wave Global, Eli Lilly and Company, Franklin Templeton, InVivium Capital, Lightswitch Capital, Point72, What If Ventures, Windham Venture Partners	No source link
Evidence No source brief is attached to this record. Sources · 0 No original source link on this record. UniqueBase news brief ↗Full English brief and original title Investors Alexandria Venture Investments, Alpha Wave Global, Eli Lilly and Company, Franklin Templeton, InVivium Capital, Lightswitch Capital, Point72, What If Ventures, Windham Venture Partners
Nov 1, 2022	$35M · Series B	Alkeon Capital, Apeiron Investment Group, Gaingels, Korify Capital, Lightswitch Capital, Novartis Pharma, Sobrato Capital, Valor Equity Partners, Vine Ventures, What If Ventures, Windham Venture Partners	No source link
Evidence No source brief is attached to this record. Sources · 0 No original source link on this record. UniqueBase news brief ↗Full English brief and original title Investors Alkeon Capital, Apeiron Investment Group, Gaingels, Korify Capital, Lightswitch Capital, Novartis Pharma, Sobrato Capital, Valor Equity Partners, Vine Ventures, What If Ventures, Windham Venture Partners

Select ▸ on a row to see its source brief and links.

Valuation · 2

Amounts as reported; USD estimates shown only when they match

Listed 2 valuation records.

Annual trendUnit: USD

No chartable valuation estimates yet.

2 listed records lack a clear date or positive USD estimate for the chart.

Date	Amount	Investors	Sources
Nov 23, 2023	— · Series C	Alexandria Venture Investments, Alpha Wave Global, Eli Lilly and Company, Franklin Templeton, InVivium Capital, Lightswitch Capital, Point72, What If Ventures, Windham Venture Partners	No source link
Evidence No source brief is attached to this record. Sources · 0 No original source link on this record. UniqueBase news brief ↗Full English brief and original title Investors Alexandria Venture Investments, Alpha Wave Global, Eli Lilly and Company, Franklin Templeton, InVivium Capital, Lightswitch Capital, Point72, What If Ventures, Windham Venture Partners
Nov 1, 2022	— · Series B	Alkeon Capital, Apeiron Investment Group, Gaingels, Korify Capital, Lightswitch Capital, Novartis Pharma, Sobrato Capital, Valor Equity Partners, Vine Ventures, What If Ventures, Windham Venture Partners	No source link
Evidence No source brief is attached to this record. Sources · 0 No original source link on this record. UniqueBase news brief ↗Full English brief and original title Investors Alkeon Capital, Apeiron Investment Group, Gaingels, Korify Capital, Lightswitch Capital, Novartis Pharma, Sobrato Capital, Valor Equity Partners, Vine Ventures, What If Ventures, Windham Venture Partners

Select ▸ on a row to see its source brief and links.

Revenue

Amounts as reported; USD estimates shown only when they match

No revenue records are listed yet.

No revenue rows to list.

Sources · 0

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

一家精神健康治疗药物提供商 Alto Neuroscience是美国的一家精神健康治疗药物提供商